A detailed history of Envestnet Asset Management Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 34,601 shares of EBS stock, worth $266,773. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,601
Holding current value
$266,773
% of portfolio
0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$7.72 - $11.97 $267,119 - $414,173
34,601 New
34,601 $330,000
Q1 2024

May 13, 2024

BUY
$1.5 - $3.41 $19,729 - $44,851
13,153 New
13,153 $33,000
Q3 2023

Nov 13, 2023

BUY
$3.17 - $7.91 $74,599 - $186,146
23,533 New
23,533 $80,000
Q4 2022

Feb 07, 2023

BUY
$11.0 - $21.45 $25,267 - $49,270
2,297 Added 16.87%
15,913 $187,000
Q3 2022

Nov 10, 2022

SELL
$20.09 - $35.8 $399,469 - $711,847
-19,884 Reduced 59.36%
13,616 $286,000
Q2 2022

Aug 03, 2022

SELL
$27.42 - $43.63 $576,450 - $917,233
-21,023 Reduced 38.56%
33,500 $1.04 Million
Q1 2022

May 04, 2022

SELL
$36.48 - $52.22 $269,550 - $385,853
-7,389 Reduced 11.93%
54,523 $2.24 Million
Q4 2021

Feb 04, 2022

SELL
$33.11 - $55.01 $238,491 - $396,237
-7,203 Reduced 10.42%
61,912 $2.69 Million
Q3 2021

Oct 07, 2021

BUY
$50.07 - $66.05 $2.21 Million - $2.91 Million
44,085 Added 176.13%
69,115 $3.46 Million
Q2 2021

Aug 04, 2021

SELL
$56.61 - $80.46 $788,294 - $1.12 Million
-13,925 Reduced 35.75%
25,030 $1.58 Million
Q1 2021

May 04, 2021

BUY
$86.23 - $125.19 $84,850 - $123,186
984 Added 2.59%
38,955 $3.62 Million
Q4 2020

Feb 02, 2021

BUY
$79.17 - $111.47 $221,280 - $311,558
2,795 Added 7.95%
37,971 $3.4 Million
Q3 2020

Oct 09, 2020

SELL
$81.91 - $134.94 $984,476 - $1.62 Million
-12,019 Reduced 25.47%
35,176 $3.64 Million
Q2 2020

Jul 08, 2020

SELL
$54.33 - $89.52 $147,071 - $242,330
-2,707 Reduced 5.42%
47,195 $3.73 Million
Q1 2020

Apr 23, 2020

BUY
$49.34 - $68.76 $654,495 - $912,101
13,265 Added 36.21%
49,902 $2.89 Million
Q4 2019

Feb 11, 2020

SELL
$51.21 - $59.06 $35,027 - $40,397
-684 Reduced 1.83%
36,637 $1.98 Million
Q3 2019

Oct 17, 2019

SELL
$40.6 - $57.2 $9,987 - $14,071
-246 Reduced 0.65%
37,321 $1.95 Million
Q2 2019

Aug 02, 2019

SELL
$39.92 - $53.86 $372,014 - $501,921
-9,319 Reduced 19.88%
37,567 $1.82 Million
Q1 2019

May 10, 2019

SELL
$48.23 - $66.16 $91,058 - $124,910
-1,888 Reduced 3.87%
46,886 $2.37 Million
Q4 2018

Feb 13, 2019

BUY
$55.63 - $73.24 $2.71 Million - $3.57 Million
48,774 New
48,774 $2.89 Million
Q3 2018

Nov 14, 2018

SELL
$52.05 - $66.51 $457,831 - $585,021
-8,796 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$48.33 - $55.64 $72,205 - $83,126
1,494 Added 20.46%
8,796 $445,000
Q1 2018

May 09, 2018

BUY
$44.44 - $54.39 $137,275 - $168,010
3,089 Added 73.32%
7,302 $384,000
Q4 2017

Feb 20, 2018

SELL
$37.77 - $47.75 $4,192 - $5,300
-111 Reduced 2.57%
4,213 $196,000
Q3 2017

Nov 13, 2017

SELL
$34.14 - $40.45 $52,780 - $62,535
-1,546 Reduced 26.34%
4,324 $175,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,870
5,870 $199,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.